Motley Fool Asset Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $207K | Sell |
2,614
-23
| -0.9% | -$1.96K | 0.01% | 247 |
|
|
2026
Q1 | $227K | Buy |
2,637
+335
| +15% | +$30.1K | 0.01% | 230 |
|
|
2025
Q4 | $201K | Buy |
+2,302
| New | +$175K | 0.01% | 239 |
|
|
2025
Q3 | – | Sell |
-33,469
| Closed | -$1.98M | – | 243 |
|
|
2025
Q2 | $1.98M | Sell |
33,469
-123,809
| -79% | -$8M | 0.09% | 153 |
|
|
2025
Q1 | $11.5M | Sell |
157,278
-14,170
| -8% | -$1.17M | 0.65% | 31 |
|
|
2024
Q4 | $14.2M | Buy |
171,448
+15,240
| +10% | +$1.2M | 0.74% | 28 |
|
|
2024
Q3 | $11M | Sell |
156,208
-44,942
| -22% | -$3.17M | 0.65% | 39 |
|
|
2024
Q2 | $13.7M | Sell |
201,150
-12,667
| -6% | -$757K | 0.91% | 26 |
|
|
2024
Q1 | $11.5M | Buy |
213,817
+151,623
| +244% | +$8.15M | 0.74% | 38 |
|
|
2023
Q4 | $3.31M | Buy |
62,194
+13,943
| +29% | +$680K | 0.25% | 85 |
|
|
2023
Q3 | $2.4M | Buy |
48,251
+1,540
| +3% | +$86.1K | 0.19% | 93 |
|
|
2023
Q2 | $2.78M | Sell |
46,711
-564
| -1% | -$32.1K | 0.25% | 78 |
|
|
2023
Q1 | $2.68M | Sell |
47,275
-3,384
| -7% | -$217K | 0.3% | 69 |
|
|
2022
Q4 | $3.76M | Sell |
50,659
-5,068
| -9% | -$345K | 0.42% | 57 |
|
|
2022
Q3 | $3.32M | Sell |
55,727
-2,697
| -5% | -$162K | 0.33% | 69 |
|
|
2022
Q2 | $3.35M | Sell |
58,424
-5,624
| -9% | -$370K | 0.32% | 72 |
|
|
2022
Q1 | $4.72M | Sell |
64,048
-12,842
| -17% | -$893K | 0.35% | 65 |
|
|
2021
Q4 | $5.55M | Sell |
76,890
-3,911
| -5% | -$284K | 0.35% | 75 |
|
|
2021
Q3 | $6.19M | Sell |
80,801
-1,323
| -2% | -$106K | 0.4% | 64 |
|
|
2021
Q2 | $6.37M | Sell |
82,124
-4,410
| -5% | -$314K | 0.42% | 62 |
|
|
2021
Q1 | $5.34M | Buy |
86,534
+13,230
| +18% | +$838K | 0.38% | 70 |
|
|
2020
Q4 | $4.78M | Buy |
73,304
+13,230
| +22% | +$761K | 0.36% | 69 |
|
|
2020
Q3 | $2.95M | Buy |
60,074
+21,333
| +55% | +$1.1M | 0.26% | 78 |
|
|
2020
Q2 | $1.85M | Buy |
38,741
+3,355
| +9% | +$162K | 0.18% | 83 |
|
|
2020
Q1 | $1.5M | Sell |
35,386
-305
| -0.9% | -$15.1K | 0.2% | 82 |
|
|
2019
Q4 | $2.1M | Sell |
35,691
-1,220
| -3% | -$66.2K | 0.23% | 80 |
|
|
2019
Q3 | $1.89M | Sell |
36,911
-610
| -2% | -$29.1K | 0.22% | 74 |
|
|
2019
Q2 | $1.59M | Buy |
37,521
+610
| +2% | +$26.5K | 0.18% | 85 |
|
|
2019
Q1 | $1.82M | Buy |
36,911
+6,100
| +20% | +$276K | 0.21% | 84 |
|
|
2018
Q4 | $1.33M | Buy |
+30,811
| New | +$1.54M | 0.19% | 84 |
|
Other funds holding GMED
JT
SC
Motley Fool Asset Management's GMED Position: Q2 2026 in Review
Motley Fool Asset Management reduced its Globus Medical (GMED) stake by 0.87% in Q2 2026, selling an estimated $1.96K and leaving 2,614 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #247.
Motley Fool Asset Management first reported a position in GMED in Q4 2018 and has held it in 30 quarters since. The position peaked at $14.2M in Q4 2024. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Motley Fool Asset Management held 2,614 shares of Globus Medical worth $207K as of Q2 2026.
- Motley Fool Asset Management sold 23 Globus Medical shares in Q2 2026, an estimated $1.96K.
- Globus Medical made up 0.01% of Motley Fool Asset Management's portfolio in Q2 2026, its #247 holding.
- Motley Fool Asset Management first reported a position in Globus Medical in Q4 2018 and has held it in 30 quarters since.
- Motley Fool Asset Management's Globus Medical position peaked at $14.2M in Q4 2024.
- 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.